Itraconazole

Revision as of 20:51, 22 September 2019 by ClaireLewis (talk | contribs) (References)

Administration

  • Type: Antifungal
  • Dosage Forms: Capsule, solution (for oropharyngeal/esophageal candida)
  • Routes of Administration:
  • Common Trade Names:

Adult Dosing

  • 200mg PO 1-4 times per day

Pediatric Dosing

  • > 5y: 2.5-10mg/kg 2-3 times per day

Special Populations

Renal Dosing

  • Adult: No adjustment
  • Pediatric:

Hepatic Dosing

  • Adult: No adjustment
  • Pediatric:

Contraindications

  • Allergy to class/drug
  • Concomitant use of CYP3A4 substrates (e.g. ergots, lurasidone, methadone, oral midazolam, simvastatin, ticagrelor, and triazolam)
  • Ventricular dysfunction (relative)

Adverse Reactions

Serious

Common

  • Nausea/vomiting, diarrhea, abdominal pain
  • Headache, dizziness
  • Edema
  • Pruritus, rash
  • URI symptoms

Pharmacology

  • Half-life: 32-96h
  • Metabolism: Hepatic, P450 CYP3A4
  • Excretion: Urine, Feces

Mechanism of Action

  • Inhibits synthesis of ergosterol (fungal cell membrane component)

Comments

See Also

References